These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18628481)

  • 1. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The skeletal impact of the chemotherapeutic agent etoposide.
    Koh AJ; Sinder BP; Entezami P; Nilsson L; McCauley LK
    Osteoporos Int; 2017 Aug; 28(8):2321-2333. PubMed ID: 28429052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor effects of Peiminine and Doxorubicin on breast cancer through enhancing DNA damage via ZEB1.
    Xu J; Zhang Z; Hu H; Yang Y; Xiao C; Xi L; Lu J; Tian S; Zhao H
    Biomed Pharmacother; 2024 Apr; 173():116353. PubMed ID: 38432128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment affects load to failure and microdamage accumulation in healthy and osteolytic rat vertebrae.
    Tolgyesi A; Huang C; Akens M; Kiss A; Hardisty M; Whyne CM
    J Mech Behav Biomed Mater; 2024 Mar; 151():106382. PubMed ID: 38211499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate Ion-Responsive and Calcium Peroxide-Based Nanomedicine for Bone-Targeted Treatment of Breast Cancer Bone Metastasis.
    Fan D; Li J; Li L; An M; Yang H; Zhou G; Gao S; Bottini M; Zhang J; Ge K
    Adv Healthc Mater; 2024 Aug; ():e2402216. PubMed ID: 39109966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.
    Ottewell PD; Wang N; Brown HK; Reeves KJ; Fowles CA; Croucher PI; Eaton CL; Holen I
    Clin Cancer Res; 2014 Jun; 20(11):2922-32. PubMed ID: 24687923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGF
    Morita M; Arshad F; Quayle LA; George CN; Lefley DV; Kalajzic I; Balsubramanian M; Cebe T; Reilly G; Bishop NJ; Ottewell PD
    Bone Rep; 2024 Sep; 22():101795. PubMed ID: 39185375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer.
    Nasulewicz-Goldeman A; Goldeman W; Papiernik D; Nowak M; Mrówczyńska E; Wietrzyk J
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37232374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis.
    Zhou J; Down JM; George CN; Murphy J; Lefley DV; Tulotta C; Alsharif MA; Leach M; Ottewell PD
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women.
    Canuas-Landero VG; George CN; Lefley DV; Corness H; Muthana M; Wilson C; Ottewell PD
    Front Endocrinol (Lausanne); 2021; 12():749428. PubMed ID: 34733240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer.
    Tulotta C; Lefley DV; Moore CK; Amariutei AE; Spicer-Hadlington AR; Quayle LA; Hughes RO; Ahmed K; Cookson V; Evans CA; Vadakekolathu J; Heath P; Francis S; Pinteaux E; Pockley AG; Ottewell PD
    NPJ Breast Cancer; 2021 Jul; 7(1):95. PubMed ID: 34290237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-Induced Senescence Drives Bone Loss.
    Yao Z; Murali B; Ren Q; Luo X; Faget DV; Cole T; Ricci B; Thotala D; Monahan J; van Deursen JM; Baker D; Faccio R; Schwarz JK; Stewart SA
    Cancer Res; 2020 Mar; 80(5):1171-1182. PubMed ID: 31932453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?
    Ottewell P; Wilson C
    Breast Cancer (Auckl); 2019; 13():1178223419843501. PubMed ID: 31555046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid.
    Hughes R; Chen X; Hunter KD; Hobbs JK; Holen I; Brown NJ
    FASEB J; 2019 Nov; 33(11):12768-12779. PubMed ID: 31490705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Dormancy in Bone.
    Clements ME; Johnson RW
    Curr Osteoporos Rep; 2019 Oct; 17(5):353-361. PubMed ID: 31468498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine models of breast cancer bone metastasis.
    Wright LE; Ottewell PD; Rucci N; Peyruchaud O; Pagnotti GM; Chiechi A; Buijs JT; Sterling JA
    Bonekey Rep; 2016; 5():804. PubMed ID: 27867497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 drives breast cancer growth and bone metastasis in vivo.
    Holen I; Lefley DV; Francis SE; Rennicks S; Bradbury S; Coleman RE; Ottewell P
    Oncotarget; 2016 Nov; 7(46):75571-75584. PubMed ID: 27765923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer.
    Yardley DA
    Breast Cancer (Dove Med Press); 2016; 8():73-82. PubMed ID: 27217795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts.
    Brown HK; Ottewell PD; Evans CA; Coleman RE; Holen I
    J Bone Oncol; 2012 Sep; 1(2):47-56. PubMed ID: 26909255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?
    Russell K; Clemons M; Costa L; Addison CL
    J Bone Oncol; 2012 Jun; 1(1):12-7. PubMed ID: 26909249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.